VIVO VENTURES VI AFFIILATES FUND, L.P.

CIK 00014002453 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001400245

Recent Transactions

42 trades

Purchase
Eiger BioPharmaceuticals, Inc.
Common Stock
2016-08-18$16.00/sh+1,364→ 12,996 total
Purchase
Eiger BioPharmaceuticals, Inc.
Common Stock
2016-08-18$16.00/sh+186,136→ 1,774,096 total
Sale
Sagent Pharmaceuticals, Inc.
Common Stock
2016-04-21$13.55/sh−2,299→ 3,456,332 total
Sale
Sagent Pharmaceuticals, Inc.
Common Stock
2016-04-21$13.55/sh−17→ 25,320 total
Sale
Sagent Pharmaceuticals, Inc.
Common Stock
2016-04-21$13.55/sh−2,299→ 3,456,332 total
Sale
Sagent Pharmaceuticals, Inc.
Common Stock
2016-04-21$13.55/sh−17→ 25,320 total
Sale
Sagent Pharmaceuticals, Inc.
Common Stock
2015-11-04$15.45/sh−532,119→ 3,458,631 total
Sale
Sagent Pharmaceuticals, Inc.
Common Stock
2015-11-04$15.45/sh−3,898→ 25,337 total
Sale
Sagent Pharmaceuticals, Inc.
Common Stock
2015-11-03$16.32/sh−490→ 29,235 total
Sale
Sagent Pharmaceuticals, Inc.
Common Stock
2015-11-03$16.32/sh−66,793→ 3,990,750 total
Sale
Sagent Pharmaceuticals, Inc.
Common Stock
2015-11-02$16.87/sh−680→ 29,725 total
Sale
Sagent Pharmaceuticals, Inc.
Common Stock
2015-11-02$16.87/sh−92,843→ 4,057,543 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Series B Convertible Preferred Stock
2015-04-14−2,476,452→ 0 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14+2,476,452→ 2,476,452 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14+304,438→ 3,189,832 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Convertible Promissory Note
2015-04-14−387,960→ 0 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Convertible Promissory Note
2015-04-14−304,438→ 0 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14+2,476,452→ 2,476,452 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14+387,960→ 2,882,554 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14+2,230→ 3,192,064 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Series B Convertible Preferred Stock
2015-04-14−2,476,452→ 0 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Series B Convertible Preferred Stock
2015-04-14−18,142→ 0 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Convertible Promissory Note
2015-04-14−2,230→ 0 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14+18,142→ 2,494,594 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14+2,842→ 2,885,396 total
Purchase
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14$5.00/sh+7,364→ 4,204,564 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14+304,438→ 3,189,834 total
Purchase
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14$5.00/sh+1,005,136→ 4,197,200 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Convertible Promissory Note
2015-04-14−2,842→ 0 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14+2,842→ 2,885,394 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Convertible Promissory Note
2015-04-14−387,960→ 0 total
Purchase
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14$5.00/sh+1,005,136→ 4,197,198 total
Purchase
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14$5.00/sh+7,364→ 4,204,562 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Convertible Promissory Note
2015-04-14−2,842→ 0 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Convertible Promissory Note
2015-04-14−304,438→ 0 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Series B Convertible Preferred Stock
2015-04-14−18,140→ 0 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Convertible Promissory Note
2015-04-14−2,230→ 0 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14+387,960→ 2,882,552 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14+18,140→ 2,494,592 total
Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2015-04-14+2,230→ 3,192,062 total
Sale
Sagent Pharmaceuticals, Inc.
Common Stock
2013-09-16$21.25/sh−618,171→ 4,150,386 total
Sale
Sagent Pharmaceuticals, Inc.
Common Stock
2013-09-16$21.25/sh−4,529→ 30,405 total

Companies

Recent Filings

Address

575 HIGH STREET, SUITE 201

PALO ALTO, CA, 94301

View on SEC.gov